![Brett Kaplan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brett Kaplan
Directeur/Membre du Conseil chez
Myeloid Therapeutics, Inc.
Profil
Brett Ilan Kaplan is currently Director at CREATE Medicines, Inc. (Massachusetts) since 2022.
Former roles include Chief Operating & Financial Officer at Climb Bio, Inc. from 2024 to 2025; President, CFO & Chief Development Officer at Chroma Medicine, Inc. from 2021 to 2024; Manager-Corporate Development at Eli Lilly & Co. from 2018 to 2021; Chief Financial Officer at Prevail Therapeutics, Inc. from 2018 to 2021; Independent Director at Compass Therapeutics, Inc. from 2020 to 2022; Managing Director at Evercore Group LLC from 2010 to 2018; Vice President at Cowen & Co. LLC in 2010; Director-Corporate Development at Cubist Pharmaceuticals LLC; Principal at Biopure Corp.
Education includes an MBA and a doctorate from the University of the Witwatersrand, both conferred in 1997.
Postes actifs de Brett Kaplan
| Sociétés | Poste | Début |
|---|---|---|
Myeloid Therapeutics, Inc.
 Myeloid Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic drugs for the treatment of tumors and autoimmune diseases | Directeur/Membre du Conseil | 30/06/2022 |
Anciens postes connus de Brett Kaplan
| Sociétés | Poste | Fin |
|---|---|---|
| CLIMB BIO, INC. | Directeur Financier/CFO | 23/05/2025 |
Chroma Medicine, Inc.
 Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Manufactures genomic medicines | Directeur Financier/CFO | 26/08/2024 |
| COMPASS THERAPEUTICS, INC. | Directeur/Membre du Conseil | 25/02/2022 |
| PREVAIL THERAPEUTICS INC. | Directeur Financier/CFO | 01/03/2021 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/03/2021 |
Formation de Brett Kaplan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
97
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
Cowen & Co. LLC
 Cowen & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Biopure Corp.
 Biopure Corp. Pharmaceuticals: MajorHealth Technology Manufactures intravenous pharmaceuticals | Health Technology |
University of the Witwatersrand
 University of the Witwatersrand Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Evercore Group LLC
 Evercore Group LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Prevail Therapeutics, Inc.
 Prevail Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes therapeutics for neurodegenerative diseases | Health Technology |
Eliem Therapeutics, Inc.
 Eliem Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders | Health Technology |
Myeloid Therapeutics, Inc.
Myeloid Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic drugs for the treatment of tumors and autoimmune diseases | Health Technology |
Compass Therapeutics, Inc.
 Compass Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage oncology biopharmaceutical company that develops antibody based therapeutics to treat multiple human diseases | Health Technology |
Chroma Medicine, Inc.
Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Manufactures genomic medicines | Health Technology |
